About: BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.21 (-3.80%)
BLRX NASDAQ BioLineRx Ltd
BioLineRx Ltd share price
BLRX price activity
Last Price
$2.210
Change (24hr)
-0.09 USD (-3.80%)
Volume
24.03K
Volume (4w avg)
-
Open
$2.28
Day Range
$2.16 - $2.37
Previous Close
$2.29
Last Trade
07 Oct, 8:00 pm GMT+0
Delayed
07 Oct, 8:00 pm GMT+0
BLRX price performance
Delayed
07 Oct, 8:00 pm GMT+0
BLRX Market Signals